[ad_1]
In a statement, France’s Sanofi and Britain’s GSK said they had “signed a declaration of intent with Alliance for Vaccines (Gavi)”, the legal administrator of the international vaccine procurement and distribution mechanism – Covax (which brings together several countries ), “In order to ensure that each participating country has fair and equitable access to possible vaccines against SARS-CoV-2”.
Therefore, “they intend to make available” to the program “200 million doses of the adjuvant recombinant protein vaccine against the new coronavirus, if approved by regulatory authorities and subject to contract award”.
Sanofi and GSK, who are jointly developing a candidate vaccine, launched a clinical trial in humans in September, “in which 440 participants were recruited.”
The two companies expect to obtain the first results “at the beginning of December 2020 and to be able to start a phase III test by the end of the year”.
“If the data from these tests are compelling enough to register an application for approval, an application for regulatory approval must be submitted to health authorities in the first half of 2021,” the two groups specified.
“The commitment we collectively make today offers us better opportunities to control the pandemic,” said Thomas Triomphe, executive vice president and global head of Sanofi Pasteur, quoted in the statement, which highlighted the “willingness to make it possible” for your vaccines. accessible to the most vulnerable populations anywhere in the world.
“Since we began developing SARS-CoV-2 vaccines, GSK has been committed to making them available to everyone, everywhere,” said Roger Connor, president of GSK Vaccines.
In a separate statement, Gavi called the announcement an “important step”, noting that his goal is to collect two billion vaccines by the end of 2021.
In total, according to the latest official data, 184 countries have so far joined the international vaccine purchase and distribution mechanism: 92 low- and middle-income countries that will receive free doses and 92 “high-income” countries that will pass through Covax to stock up. , but they will have to pay the doses out of their own pocket.
Source link
